Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 11172470)

1.
2.

Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.

Dobiásová M, Raslová K, Rauchová H, Vohnout B, Ptácková K, Frohlich J.

Physiol Res. 2001;50(1):1-8.

3.

Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.

Scaglione L, Bergerone S, Gambino R, Imazio M, Macchia G, Cravetto A, Gaschino G, Baralis G, Rosettani E, Pagano G, Cassader M.

Nutr Metab Cardiovasc Dis. 1999 Jun;9(3):118-24.

PMID:
10464784
4.
5.

Genetic polymorphism of 5,10-methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population.

Nakai K, Fusazaki T, Suzuki T, Ohsawa M, Ogiu N, Kamata J, Kawazoe K, Nakai K, Itoh C, Yanagisawa M, Ishida T, Hiramori K.

Coron Artery Dis. 2000 Feb;11(1):47-51.

PMID:
10715806
6.
7.

Association of methylenetetrahydrofolate (MTHFR) and apolipoprotein E (apo E) genotypes with homocysteine, vitamin and lipid levels in carotid stenosis.

Zuntar I, Antoljak N, Vrkić N, Topić E, Kujundzić N, Demarin V, Vuković V.

Coll Antropol. 2006 Dec;30(4):871-8.

PMID:
17243563
8.
9.

Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.

Tanis BC, Blom HJ, Bloemenkamp DG, van den Bosch MA, Algra A, van der Graaf Y, Rosendaal FR.

J Thromb Haemost. 2004 Jan;2(1):35-41.

PMID:
14717963
10.

Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study.

Aasvee K, Jauhiainen M, Kurvinen E, Tur I, Sundvall J, Roovere T, Baburin A.

Scand J Clin Lab Invest. 2006;66(3):191-9.

PMID:
16714248
11.

Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction.

Mayer B, Lieb W, Götz A, König IR, Kauschen LF, Linsel-Nitschke P, Pomarino A, Holmer S, Hengstenberg C, Doering A, Loewel H, Hense HW, Ziegler A, Erdmann J, Schunkert H.

J Hypertens. 2006 Oct;24(10):1965-70.

PMID:
16957555
12.
14.

MTHFR gene polymorphism, homocysteine and cardiovascular disease.

Cortese C, Motti C.

Public Health Nutr. 2001 Apr;4(2B):493-7. Review.

PMID:
11683544
16.

Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia.

Szczeklik A, Sanak M, Jankowski M, Dropiński J, Czachór R, Musiał J, Axenti I, Twardowska M, Brzostek T, Tendera M.

Am J Med Genet. 2001 Jun 1;101(1):36-9.

PMID:
11343335
17.

Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease.

Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, Hatzigeorgiou G, Cariolou MA, Cokkinos DV.

Curr Med Res Opin. 2002;18(3):118-24.

PMID:
12094820
18.

Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction.

Gülec S, Aras O, Akar E, Tutar E, Omürlü K, Avci F, Dinçer I, Akar N, Oral D.

Clin Cardiol. 2001 Apr;24(4):281-4.

PMID:
11303694
19.
20.

Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India.

Kumar P, Luthra K, Dwivedi M, Behl VK, Pandey RM, Misra A.

Ann Clin Biochem. 2003 Jul;40(Pt 4):382-7.

PMID:
12880539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk